NO307690B1 - Anvendelse av dimetylbenzofuraner og dimetylbenzopyraner som 5-HT3-antagonister - Google Patents

Anvendelse av dimetylbenzofuraner og dimetylbenzopyraner som 5-HT3-antagonister

Info

Publication number
NO307690B1
NO307690B1 NO951980A NO951980A NO307690B1 NO 307690 B1 NO307690 B1 NO 307690B1 NO 951980 A NO951980 A NO 951980A NO 951980 A NO951980 A NO 951980A NO 307690 B1 NO307690 B1 NO 307690B1
Authority
NO
Norway
Prior art keywords
pct
date jun
represents hydrogen
sec
formula
Prior art date
Application number
NO951980A
Other languages
English (en)
Norwegian (no)
Other versions
NO951980D0 (no
NO951980L (no
Inventor
Georges Henri Paul Van Daele
Jean-Paul Rene Marie A Bosmans
Willy Joannes Carolu Laerhoven
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO951980D0 publication Critical patent/NO951980D0/no
Publication of NO951980L publication Critical patent/NO951980L/no
Publication of NO307690B1 publication Critical patent/NO307690B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dental Preparations (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO951980A 1992-11-20 1995-05-19 Anvendelse av dimetylbenzofuraner og dimetylbenzopyraner som 5-HT3-antagonister NO307690B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97901392A 1992-11-20 1992-11-20
PCT/EP1993/003206 WO1994012494A1 (en) 1992-11-20 1993-11-15 Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists

Publications (3)

Publication Number Publication Date
NO951980D0 NO951980D0 (no) 1995-05-19
NO951980L NO951980L (no) 1995-05-19
NO307690B1 true NO307690B1 (no) 2000-05-15

Family

ID=25526607

Family Applications (2)

Application Number Title Priority Date Filing Date
NO951980A NO307690B1 (no) 1992-11-20 1995-05-19 Anvendelse av dimetylbenzofuraner og dimetylbenzopyraner som 5-HT3-antagonister
NO995762A NO308530B1 (no) 1992-11-20 1999-11-24 Cis-3-metoksy-4-amino-piperidinforbindelser for fremstilling av dimetylbenzofuraner og dimetylbenzopyraner

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO995762A NO308530B1 (no) 1992-11-20 1999-11-24 Cis-3-metoksy-4-amino-piperidinforbindelser for fremstilling av dimetylbenzofuraner og dimetylbenzopyraner

Country Status (31)

Country Link
US (2) US5674868A (de)
EP (1) EP0669919B1 (de)
JP (1) JP2830952B2 (de)
KR (1) KR0166661B1 (de)
AT (1) ATE176232T1 (de)
AU (1) AU680640B2 (de)
BG (1) BG62489B1 (de)
BR (1) BR9307477A (de)
CA (1) CA2149044C (de)
CZ (1) CZ287262B6 (de)
DE (1) DE69323322T2 (de)
DK (1) DK0669919T3 (de)
ES (1) ES2129615T3 (de)
FI (1) FI952458A (de)
GR (1) GR3029831T3 (de)
HU (2) HUT72740A (de)
IL (3) IL107654A (de)
LV (1) LV10956B (de)
MX (1) MX9307257A (de)
NO (2) NO307690B1 (de)
NZ (1) NZ257854A (de)
OA (1) OA10158A (de)
PL (1) PL176051B1 (de)
RO (1) RO115160B1 (de)
RU (1) RU2116072C1 (de)
SG (1) SG47488A1 (de)
SK (1) SK282378B6 (de)
TW (1) TW294595B (de)
UA (1) UA49792C2 (de)
WO (1) WO1994012494A1 (de)
ZA (1) ZA938676B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
EP0975327B1 (de) 1997-04-18 2003-07-02 Janssen Pharmaceutica N.V. Verwendung von 5ht3 antagonisten zum fördern der darmspülung
PL190296B1 (pl) * 1997-07-11 2005-11-30 Janssen Pharmaceutica Nv Zastosowanie (+)-norcyzaprydu
US6239122B1 (en) * 2000-01-05 2001-05-29 Joy Ann Steele Method of treatment of nausea, vomiting, and other disorders using estrogens
EP1646615B1 (de) * 2003-06-06 2009-08-26 Vertex Pharmaceuticals Incorporated Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
EP1709011B1 (de) 2003-11-20 2015-07-29 Janssen Pharmaceutica NV 7-phenylalkylsubstituierte 2-chinolinone und 2-chinoxalinone als inhibitoren von poly(adp-ribose)polymerase
WO2005054201A1 (en) 2003-11-20 2005-06-16 Janssen Pharmaceutica N.V. 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
EA014955B1 (ru) 2004-06-30 2011-04-29 Янссен Фармацевтика Н. В. Производные фталазина в качестве ингибиторов parp
US8080557B2 (en) 2004-06-30 2011-12-20 Janssen Pharmaceutica, Nv Quinazolinedione derivatives as PARP inhibitors
EA012416B1 (ru) * 2004-06-30 2009-10-30 Янссен Фармацевтика Н.В. Производные замещенного 2-алкилхиназолинона как ингибиторы parp
JP5545955B2 (ja) 2007-03-08 2014-07-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Parpおよびtank阻害剤としてのキノリノン誘導体
PL2215075T3 (pl) 2007-10-26 2014-04-30 Janssen Pharmaceutica Nv Pochodne chinolinonu jako inhibitory PARP
WO2009118384A1 (en) 2008-03-27 2009-10-01 Janssen Pharmaceutica Nv Quinazolinone derivatives as tubulin polymerization inhibitors
RU2490260C2 (ru) 2008-03-27 2013-08-20 Янссен Фармацевтика Нв Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибиторов parp и ингибиторов полимеризации тубулина

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
ZW12187A1 (en) * 1986-07-03 1989-02-01 Janssen Pharmaceutica Nv 4-(aroylamino)piperidinebutanamide derivatives
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives

Also Published As

Publication number Publication date
HUT72740A (en) 1996-05-28
NO995762D0 (no) 1999-11-24
ES2129615T3 (es) 1999-06-16
DK0669919T3 (da) 1999-09-13
US5863923A (en) 1999-01-26
NO951980D0 (no) 1995-05-19
FI952458A0 (fi) 1995-05-19
KR0166661B1 (ko) 1999-01-15
WO1994012494A1 (en) 1994-06-09
DE69323322T2 (de) 1999-09-09
JP2830952B2 (ja) 1998-12-02
SK67595A3 (en) 1995-11-08
OA10158A (en) 1996-12-18
EP0669919B1 (de) 1999-01-27
LV10956B (en) 1996-10-20
US5674868A (en) 1997-10-07
BG99593A (en) 1995-12-29
NZ257854A (en) 1997-04-24
SG47488A1 (en) 1998-04-17
JPH08505840A (ja) 1996-06-25
CA2149044A1 (en) 1994-06-09
RU2116072C1 (ru) 1998-07-27
CZ287262B6 (en) 2000-10-11
PL309045A1 (en) 1995-09-18
UA49792C2 (uk) 2002-10-15
RU95113434A (ru) 1997-03-10
HU211546A9 (en) 1995-12-28
NO951980L (no) 1995-05-19
SK282378B6 (sk) 2002-01-07
IL107654A (en) 1998-01-04
RO115160B1 (ro) 1999-11-30
BR9307477A (pt) 1999-06-29
IL119273A0 (en) 1996-12-05
CZ125895A3 (en) 1995-10-18
NO308530B1 (no) 2000-09-25
IL119273A (en) 2000-07-16
CA2149044C (en) 2007-04-03
LV10956A (lv) 1995-12-20
NO995762L (no) 1995-05-19
TW294595B (de) 1997-01-01
EP0669919A1 (de) 1995-09-06
PL176051B1 (pl) 1999-03-31
FI952458A (fi) 1995-05-19
MX9307257A (es) 1994-05-31
AU680640B2 (en) 1997-08-07
AU5465994A (en) 1994-06-22
ZA938676B (en) 1995-05-19
HU9501476D0 (en) 1995-07-28
IL107654A0 (en) 1994-02-27
DE69323322D1 (de) 1999-03-11
BG62489B1 (bg) 1999-12-30
GR3029831T3 (en) 1999-06-30
ATE176232T1 (de) 1999-02-15

Similar Documents

Publication Publication Date Title
NO307690B1 (no) Anvendelse av dimetylbenzofuraner og dimetylbenzopyraner som 5-HT3-antagonister
SE0104332D0 (sv) Therapeutic agents
AU6073596A (en) Intermediates useful in the preparation of 5-HT4 receptor antagonists
GB9121456D0 (en) Triazole antifungal agents
FI943931A (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
DK0871626T3 (da) Triazoloner som apolipoprotein-B syntheseinhibitorer
DE69304930D1 (de) 4-chinolinyl derivate mit anti-helicobacter wirkung
LV11545A (lv) Pozitivas inotropas un lusitropas iedarbibas pirolohinolinona atvasinajumi